These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15580158)

  • 1. Immunotherapy for atherosclerosis: an emerging paradigm.
    Shah PK; Chyu KY; Nilsson J
    Rev Cardiovasc Med; 2004; 5(4):194-203. PubMed ID: 15580158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination for atherosclerosis: a novel therapeutic paradigm.
    Shah PK; Chyu KY; Fredrikson GN; Nilsson J
    Expert Rev Vaccines; 2004 Dec; 3(6):711-6. PubMed ID: 15606356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human antibodies against aldehyde-modified apolipoprotein B-100 peptide sequences inhibit atherosclerosis.
    Schiopu A; Bengtsson J; Söderberg I; Janciauskiene S; Lindgren S; Ares MP; Shah PK; Carlsson R; Nilsson J; Fredrikson GN
    Circulation; 2004 Oct; 110(14):2047-52. PubMed ID: 15451805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lesion development and response to immunization reveal a complex role for CD4 in atherosclerosis.
    Zhou X; Robertson AK; Rudling M; Parini P; Hansson GK
    Circ Res; 2005 Mar; 96(4):427-34. PubMed ID: 15662027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequences.
    Fredrikson GN; Söderberg I; Lindholm M; Dimayuga P; Chyu KY; Shah PK; Nilsson J
    Arterioscler Thromb Vasc Biol; 2003 May; 23(5):879-84. PubMed ID: 12649092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A vaccine for protection against atherosclerosis. Oxidized LDL plays a major role in the immunologic defence].
    Nilsson J; Fredrikson GN
    Lakartidningen; 2004 May; 101(19):1700-1, 1704-5. PubMed ID: 15188583
    [No Abstract]   [Full Text] [Related]  

  • 7. Atheroprotective immunization with MDA-modified apo B-100 peptide sequences is associated with activation of Th2 specific antibody expression.
    Fredrikson GN; Andersson L; Söderberg I; Dimayuga P; Chyu KY; Shah PK; Nilsson J
    Autoimmunity; 2005 Mar; 38(2):171-9. PubMed ID: 16040338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulation of atherosclerosis with a vaccine.
    Shah PK; Chyu KY; Fredrikson GN; Nilsson J
    Nat Clin Pract Cardiovasc Med; 2005 Dec; 2(12):639-46. PubMed ID: 16306920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies against LDL progressively oxidized by myeloperoxidase react with ApoB-100 protein moiety and human atherosclerotic lesions.
    Moguilevsky N; Zouaoui Boudjeltia K; Babar S; Delrée P; Legssyer I; Carpentier Y; Vanhaeverbeek M; Ducobu J
    Biochem Biophys Res Commun; 2004 Oct; 323(4):1223-8. PubMed ID: 15451427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with apo B peptide vaccines inhibits atherosclerosis in human apo B-100 transgenic mice without inducing an increase in peptide-specific antibodies.
    Fredrikson GN; Björkbacka H; Söderberg I; Ljungcrantz I; Nilsson J
    J Intern Med; 2008 Dec; 264(6):563-70. PubMed ID: 18783480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atherosclerosis: immunopathogenesis and immunotherapy.
    Ohashi R; Mu H; Yao Q; Chen C
    Med Sci Monit; 2004 Nov; 10(11):RA255-60. PubMed ID: 15507866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein B100 autoimmunity and atherosclerosis - disease mechanisms and therapeutic potential.
    Nilsson J; Björkbacka H; Fredrikson GN
    Curr Opin Lipidol; 2012 Oct; 23(5):422-8. PubMed ID: 22814703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccines modulating lipoprotein autoimmunity as a possible future therapy for cardiovascular disease.
    Nilsson J; Fredrikson GN; Björkbacka H; Chyu KY; Shah PK
    J Intern Med; 2009 Sep; 266(3):221-31. PubMed ID: 19702790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune therapy for age-related diseases.
    Weksler ME; Pawelec G; Franceschi C
    Trends Immunol; 2009 Jul; 30(7):344-50. PubMed ID: 19541533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.
    Gounopoulos P; Merki E; Hansen LF; Choi SH; Tsimikas S
    Minerva Cardioangiol; 2007 Dec; 55(6):821-37. PubMed ID: 18091649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization using an Apo B-100 related epitope reduces atherosclerosis and plaque inflammation in hypercholesterolemic apo E (-/-) mice.
    Chyu KY; Zhao X; Reyes OS; Babbidge SM; Dimayuga PC; Yano J; Cercek B; Fredrikson GN; Nilsson J; Shah PK
    Biochem Biophys Res Commun; 2005 Dec; 338(4):1982-9. PubMed ID: 16288717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active and passive immunization for atherosclerosis.
    Chyu KY; Nilsson J; Shah PK
    Curr Opin Mol Ther; 2007 Apr; 9(2):176-82. PubMed ID: 17458172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chronic inflammation, autoimmunity and atherosclerosis].
    Zhu JJ; Wang X
    Sheng Li Ke Xue Jin Zhan; 2002 Oct; 33(4):327-31. PubMed ID: 12650069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Atherosclerosis and the system of immunity].
    Nagornev VA; Pigarevskiĭ PV; Ogurtsov RP; Denisenko AD
    Arkh Patol; 1985; 47(4):15-21. PubMed ID: 3873930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunization--future cure against atherosclerosis?].
    Frostegård J
    Lakartidningen; 2004 May; 101(19):1678-9. PubMed ID: 15188580
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.